
US Sickle Cell Patients Face Severe Access Gap for Red Blood Cell Exchange Therapy
A new survey reveals that fewer than 3% of US sickle cell patients receive red blood cell exchange therapy, despite 91% of providers having access to the technology. Barriers include insurance coverage, limited donor blood, and a lack of specialized centers, particularly in rural areas.













